Kimi Iguchi, CFO & Treasurer at Sage Therapeutics, Inc. (SAGE), sold 42,906 shares at $142.84 ($6.1M) on 2018-04-23, disclosed to the SEC on 2018-04-25.
Open-market sale of $6.1M SAGE by CFO & Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $142.84 | 2,999 | $428K | 7.0% |
| 2 | $142.84 | 2,999 | $428K | 7.0% |
| 3 | $143.90 | 4,700 | $676K | 11.1% |
| 4 | $144.71 | 2,601 | $376K | 6.2% |
| 5 | $144.71 | 2,601 | $376K | 6.2% |
| 6 | $145.58 | 700 |
| $102K |
| 1.7% |
| 7 | $145.58 | 700 | $102K | 1.7% |
| 8 | $149.54 | 635 | $95K | 1.6% |
| 9 | $149.54 | 635 | $95K | 1.6% |
| 10 | $150.68 | 500 | $75K | 1.2% |
| 11 | $141.51 | 2,500 | $354K | 5.8% |
| 12 | $142.50 | 900 | $128K | 2.1% |
| 13 | $144.06 | 500 | $72K | 1.2% |
| 14 | $145.10 | 600 | $87K | 1.4% |
| 15 | $146.14 | 500 | $73K | 1.2% |
| 16 | $140.38 | 7,818 | $1.1M | 17.9% |
| 17 | $140.38 | 7,818 | $1.1M | 17.9% |
| 18 | $141.26 | 2,300 | $325K | 5.3% |
| 19 | $142.69 | 900 | $128K | 2.1% |
| Total | $142.58 avg | 42,906 | $6.1M | 100% |
| Filing → |
| SAGE | SELL | 2017-01-13 | $539K | — | Filing → |
| SAGE | SELL | 2016-11-18 | $207K | — | Filing → |
| SAGE | SELL | 2016-11-14 | $76K | — | Filing → |